Jula Inrig, CHIEF MEDICAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 2,476 shares at $37.75 ($98K) on 2026-01-06, disclosed to the SEC on 2026-01-07.
Scheduled sale ($98k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.18 | 2,031 | $82K | 82.9% |
| 2 | $37.75 | 445 | $17K | 17.1% |
| Total | $39.74 avg | 2,476 | $98K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $346K | — | Filing → |
| TVTX | SELL | 2026-02-05 | $57K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $223K | — | Filing → |